EPISODE · Oct 14, 2022 · 51 MIN
Women and Psychedelic Medicine with Dr. Gita Vaid and Dr. Kelley O'Donell
from The Rose Woman
In the next couple of weeks, we will be sharing the different live talks from the Sensing Woman: A multisensory event that took place at C24 Gallery in Chelsea, New York City, five days of Art by 50 contemporary visual artists, along with conversation, storytelling and music – altogether around the future of being female. The first in this series is about Women and Psychedelics, this panel is led by the Rose Woman Christine Mason with Gita Vaid, M.D., and Dr. Kelly O'Donell. Our guest speakers have been not just researching psychedelic-assisted therapy but have found it to be a successful tool for treating depression in some patients. Listen in and learn how psychedelics have the potential to shift how we view and manage our mental health. In this episode, we cover:What is MAPS (Multidisciplinary Association for Psychedelic Studies) and its mission?To whom are these useful?Session experience stories Healing from trauma and sufferingNature of consciousness and relationship to medicinesDifferent effects of psilocybin and ketamine in patients’ use Helpful links: Gita Vaid, MD - Gita Vaid, MD is a board certified psychiatrist and psychoanalyst practicing ketamine assisted psychotherapy in New York City. She is a co-founder of the Center for Natural Intelligence, a multidisciplinary laboratory dedicated to psychedelic psychotherapy innovation and clinical practice. Follow her on Instagram @gitavaidDr. Kelly O’Donell - Board-certified psychiatrist, psychedelic researcher, and Director of Clinical Education at the NYU Langone Center for Psychedelic Medicine.he is the a lead therapist and clinical supervisor on a number of trials of psychedelic-assisted psychotherapy (including psilocybin and MDMA) for a variety of therapeutic applications.Follow her on Instagram @mandorlawellness Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
In the next couple of weeks, we will be sharing the different live talks from the Sensing Woman: A multisensory event that took place at C24 Gallery in Chelsea, New York City, five days of Art by 50 contemporary visual artists, along with conversation, storytelling and music – altogether around the future of being female. The first in this series is about Women and Psychedelics, this panel is led by the Rose Woman Christine Mason with Gita Vaid, M.D., and Dr. Kelly O'Donell. Our guest speakers have been not just researching psychedelic-assisted therapy but have found it to be a successful tool for treating depression in some patients. Listen in and learn how psychedelics have the potential to shift how we view and manage our mental health. In this episode, we cover:What is MAPS (Multidisciplinary Association for Psychedelic Studies) and its mission?To whom are these useful?Session experience stories Healing from trauma and sufferingNature of consciousness and relationship to medicinesDifferent effects of psilocybin and ketamine in patients’ use Helpful links: Gita Vaid, MD - Gita Vaid, MD is a board certified psychiatrist and psychoanalyst practicing ketamine assisted psychotherapy in New York City. She is a co-founder of the Center for Natural Intelligence, a multidisciplinary laboratory dedicated to psychedelic psychotherapy innovation and clinical practice. Follow her on Instagram @gitavaidDr. Kelly O’Donell - Board-certified psychiatrist, psychedelic researcher, and Director of Clinical Education at the NYU Langone Center for Psychedelic Medicine.he is the a lead therapist and clinical supervisor on a number of trials of psychedelic-assisted psychotherapy (including psilocybin and MDMA) for a variety of therapeutic applications.Follow her on Instagram @mandorlawellness Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Women and Psychedelic Medicine with Dr. Gita Vaid and Dr. Kelley O'Donell
No transcript for this episode yet
Similar Episodes
Dec 5, 2025 ·50m
Oct 9, 2025 ·33m
Oct 3, 2025 ·40m
Sep 11, 2025 ·31m
Aug 27, 2025 ·39m
Aug 18, 2025 ·54m